Our company participated in the 16th annual meeting of the Chinese Medical Doctor Association Psychiatrist Branch (CPA2020) and held a satellite meeting
Sponsored by the Chinese Medical Doctor Association and the Chinese Medical Doctor Association Psychiatrist Branch, the 16th Annual Meeting of the Chinese Medical Doctor Association Psychiatrist Branch (CPA2020) will be held on November 19-21, 2020 in the form of an online and offline (Jinan) meeting. Foncoo Pharmaceutical participated in this conference and held a satellite conference. The theme of the satellite conference was: Initial treatment and maintenance of antipsychotic drugs (Interpretation of the American APA (2020) Guidelines for the Treatment of Schizophrenia), and the conference was organized by the Chinese Medical Doctor Association Psychiatrist Branch The current president, Prof. Wang Gaohua, and the first president of the Chinese Medical Doctor Association Psychiatrist Branch, Prof. Yu Xin, presided over the session; Prof. Si Tianmei from Peking University Sixth Hospital and Prof. Ma Xiancang from the First Affiliated Hospital of Xi'an Jiaotong University were the speakers. The scene attracted more than 400 doctors and more than 3,000 online attention.
▲Satellite meeting poster
▲Prof. Wang Gaohua and Prof. Yu Xin presided over
▲Professor Si Tianmei and Professor Ma Xiancang gave lectures
▲Thanks to Fangu Pharmaceutical for celebrating the launch of new products (Baiyoulin, Bailangxin)
At the end of the meeting, Professor Yu Xin concluded that the initial treatment and maintenance treatment of schizophrenia are very important, but they also face many challenges, which need to be solved by all psychiatrists. The experts and physicians who attended the meeting also warmly congratulated our company on the launch of our new products Baiyoulin (amisulpride tablets) and Bailangxin (quetiapine fumarate sustained-release tablets).